You just read:

Egalet Announces FDA Advisory Committee Meeting will Take Place August 4, 2016 for Lead Abuse-Deterrent Candidate ARYMO™ ER (Morphine Sulfate) Extended-Release Tablets

News provided by

Egalet Corporation

Jun 28, 2016, 09:11 ET